Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00276965 · ClinicalTrials.gov registry record · Phase 3
Bipolar II Depression: Lithium, SSRI, or the Combination
A Phase 3 study, sponsored by Lindner Center of HOPE.
- Completed
- Registry status
- Phase 3
- Development phase
- 139
- Enrollment target
NCT00276965 is a Phase 3 study that has completed, run by Lindner Center of HOPE. The registered enrollment target is 139 participants.
The verdict
NCT00276965, a Phase 3 study, has completed, sponsored by Lindner Center of HOPE.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 139 participants
- Enrollment target
Study Summary
This study will compare the safety and effectiveness of a mood stabilizing medication, an antidepressant medication, and a combination of both medications to treat symptoms of bipolar type II depression.
Interventions
- DRUG Sertraline
- DRUG Lithium carbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2006-09 |
| Est. Completion | 2012-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00276965
The ClinicalTrials.gov registry entry for NCT00276965 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindner Center of HOPE, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sertraline is the first listed.
NCT00276965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00276965 about?
NCT00276965 is a clinical study titled "Bipolar II Depression: Lithium, SSRI, or the Combination". This study will compare the safety and effectiveness of a mood stabilizing medication, an antidepressant medication, and a combination of both medications to treat symptoms of bipolar type II depression.
What is the current status of trial NCT00276965?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 139 participants. The study started on 2006-09. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00276965?
The interventions under investigation include: Sertraline (DRUG), Lithium carbonate (DRUG).
Who is sponsoring clinical trial NCT00276965?
This trial is sponsored by Lindner Center of HOPE, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.